Unidad de Eritropatología, Unidad de Gestión Clínica de Hematología, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC), Sevilla, Spain.
Servicios y Unidades de Referencia (CSUR) de Eritropatología Hereditaria, Hospital Sant Joan de Déu - Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Servicio de Hematología Pediátrica, Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain; Institut de Recerca, Fundació Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain.
Nefrologia (Engl Ed). 2021 Jul-Aug;41(4):373-382. doi: 10.1016/j.nefroe.2021.10.001. Epub 2021 Oct 27.
Kidney problems are among the most common complications in sickle cell disease (SCD). They occur early in childhood and are one of the main factors related to mortality in these patients. The main underlying pathogenic mechanisms are vaso-occlusion and haemolysis. The renal medulla has ideal conditions for the sickling of red cells due to its low partial pressure of oxygen, high osmolarity and acidic pH. Initially, sickle-cell formation in the vasa recta of the renal medulla causes hyposthenuria. This is universal and appears in early childhood. Microscopic and macroscopic haematuria also occur, in part related to renal papillary necrosis when the infarcts are extensive. Release of prostaglandins in the renal medulla due to ischaemia leads to an increase in the glomerular filtration rate (GFR). Adaptively, sodium reabsorption in the proximal tubule increases, accompanied by increased creatinine secretion. Therefore, the GFR estimated from creatinine may be overestimated. Focal segmental glomerulosclerosis is the most common glomerular disease. Albuminuria is very common and reduction has been found in 72.8% of subjects treated with ACE inhibitors or ARB. Recent evidence suggests that free haemoglobin has harmful effects on podocytes, and may be a mechanism involved in impaired kidney function in these patients. These effects need to be better studied in SCD, as they could provide a therapeutic alternative in sickle cell nephropathy.
肾脏问题是镰状细胞病(SCD)中最常见的并发症之一。它们在儿童早期就会发生,是这些患者死亡的主要相关因素之一。主要的潜在发病机制是血管阻塞和溶血。由于肾髓质的氧分压低、渗透压高和酸性 pH 值,其为红细胞镰变提供了理想的条件。最初,肾髓质直小血管中的镰状细胞形成会导致少尿。这是普遍存在的,并且在儿童早期就会出现。也会出现显微镜下和肉眼血尿,部分原因与梗死广泛时的肾乳头坏死有关。由于缺血导致肾髓质释放前列腺素会导致肾小球滤过率(GFR)增加。适应性地,近端肾小管中钠的重吸收增加,同时肌酐分泌增加。因此,从肌酐估计的 GFR 可能会被高估。局灶节段性肾小球硬化是最常见的肾小球疾病。蛋白尿非常常见,在接受 ACE 抑制剂或 ARB 治疗的 72.8%的患者中发现其减少。最近的证据表明,游离血红蛋白对足细胞有有害影响,可能是这些患者肾功能受损的一个机制。在 SCD 中需要更好地研究这些影响,因为它们可能为镰状细胞肾病提供治疗选择。